These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24677034)

  • 1. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
    Eslam RB; Burian A; Vila G; Sauermann R; Hammer A; Frenzel D; Minichmayr IK; Kloft C; Matzneller P; Oesterreicher Z; Zeitlinger M
    J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.
    Majcher-Peszynska J; Haase G; Sass M; Mundkowski R; Pietsch A; Klammt S; Schareck W; Drewelow B
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1093-100. PubMed ID: 18654767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections.
    Traunmüller F; Schintler MV; Spendel S; Popovic M; Mauric O; Scharnagl E; Joukhadar C
    Int J Antimicrob Agents; 2010 Jul; 36(1):84-6. PubMed ID: 20456925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of food on plasma and tissue concentrations of linezolid after multiple doses.
    Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C
    Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy.
    Koomanachai P; Keel RA; Johnson-Arbor KK; Suecof LA; Nicolau DP; Kuti JL
    Undersea Hyperb Med; 2011; 38(1):11-6. PubMed ID: 21384759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.
    Dehghanyar P; Bürger C; Zeitlinger M; Islinger F; Kovar F; Müller M; Kloft C; Joukhadar C
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2367-71. PubMed ID: 15917535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
    Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
    Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
    Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: a case report.
    Pea F; Cadeo B; Cojutti PG; Pecori D; Bassetti M
    Ther Drug Monit; 2014 Oct; 36(5):687-9. PubMed ID: 24646731
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
    Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
    Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of linezolid into sternal bone of patients undergoing cardiopulmonary bypass surgery.
    Metallidis S; Nikolaidis J; Lazaraki G; Koumentaki E; Gogou V; Topsis D; Nikolaidis P; Charokopos N; Theodoridis G
    Int J Antimicrob Agents; 2007 Jun; 29(6):742-4. PubMed ID: 17374477
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
    Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
    J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
    Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
    Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue pharmacokinetics of levofloxacin in human soft tissue infections.
    Bellmann R; Kuchling G; Dehghanyar P; Zeitlinger M; Minar E; Mayer BX; Müller M; Joukhadar C
    Br J Clin Pharmacol; 2004 May; 57(5):563-8. PubMed ID: 15089808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA.
    Swoboda S; Helbig L; Kommerell M; Simank HG; Kees F; Geiss HK; Hoppe-Tichy T; Schröder K
    Pharmazie; 2009 Jun; 64(6):407-9. PubMed ID: 19618680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
    Stein GE; Throckmorton JK; Scharmen AE; Weiss WJ; Prokai L; Smith CL; Havlichek DH
    J Antimicrob Chemother; 2013 Dec; 68(12):2852-8. PubMed ID: 23873647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
    Wiskirchen DE; Shepard A; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4170-5. PubMed ID: 21709078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration.
    Horcajada JP; Atienza R; Sarasa M; Soy D; Adán A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):550-2. PubMed ID: 19109336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.